Hemodynamic management of septic shock

Current Infectious Disease Reports

Volumn 8, Issue 5, 2006, Pages 366-372

  De Backer, Daniel ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADRENALIN; ALBUMIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DOBUTAMINE; DOPAMINE; FLUDROCORTISONE; GLYCERYL TRINITRATE; HYDROCORTISONE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; LEVOSIMENDAN; NITRIC OXIDE INHIBITOR; NORADRENALIN; OXYGEN; PHENYLEPHRINE; PHOSPHODIESTERASE III INHIBITOR; STEROID; UNCLASSIFIED DRUG; VASODILATOR AGENT; VASOPRESSIN;

ADRENAL INSUFFICIENCY; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLLOID; CRYSTALLOID; DISEASE SEVERITY; DRUG ACTIVITY; FLUID THERAPY; HEMODYNAMICS; HUMAN; HYPOTENSION; HYPOVOLEMIA; IMMUNE DEFICIENCY; MICROCIRCULATION; MULTIPLE ORGAN FAILURE; MYOCARDIAL DISEASE; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; REVIEW; SEPTIC SHOCK; SPLANCHNIC BLOOD FLOW; TACHYCARDIA; TISSUE BLOOD FLOW; TISSUE PERFUSION; VENOUS RETURN;

EID: 33749003457     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-006-0047-z     Document Type: Review

References (58)

1. Singer M, De S, V, Vitale D, et al.: Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004, 364:545-548.
2. Brealey D, Brand M, Hargreaves I, et al.: Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002, 360:219-223.
3. Hollenberg SM, Cunnion RE, Parrillo JE: Effect of septic serum on vascular smooth muscle: In vitro studies using rat aortic rings. Crit Care Med 1992, 20:993-998.
4. Landin L, Lorente JA, Renes E, et al.: Inhibition of nitric oxide synthesis improves the vasoconstrictive effects of noradrenaline in sepsis. Chest 1994, 106:250-256.
5. Pastor CM and Billiar TR: Nitric oxide causes hyporeactivity to phenylephrine in isolated perfused livers from endotoxin-treated rats. Am J Physiol 1995, 268:G177-G182.
6. Landry DW, Levin HR, Gallant EM, et al.: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997, 95:1122-1125.
7. Sharshar T, Blanchard A, Paillard M, et al.: Circulating vasopressin levels in septic shock. Crit Care Med 2003, 31:1752-1758.
8. Roth BL and Spitzer JA.: Altered hepatic vasopressin and alpha 1-adrenergic receptors after chronic endotoxin infusion. Am J Physiol 1987, 252:E699-E702.
9. Hollenberg SM, Tangora JJ, Piotrowski MJ, et al.: Impaired microvascular vasoconstrictive responses to vasopressin in septic rats. Crit Care Med 1997, 25:869-873.
10. Pinsky MR and Matuschak GM: Cardiovascular determinants of the hemodynamic response to acute endotoxemia in the dog. J Crit Care 1986, 1:18-31.
11. Ayuse T, Brienza N, Revelly JP, et al.: Alterations in liver hemodynamics in an intact porcine model of endotoxin shock. Am J Physiol 1995, 268:H1106-H1114.
12. O'Dwyer ST, Michie HR, Ziegler TR, et al.: A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 1988, 123:1459-1464.
13. Fink MP, Antonsson JB, Wang H, et al.: Increased intestinal permeability in endotoxic pigs. Arch Surg 1991, 126:211-218.
14. Stephan F, Novara A, Tournier B, et al.: Determination of total effective vascular compliance in patients with sepsis syndrome. Am J Respir Crit Care Med 1998, 157:50-56.
15. Suffredini AF, Fromm RE, Parker MM, et al.: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989, 321:280-287.
16. Nelson DP, Beyer C, Samsel RW, et al.: Pathological supply dependence of O2 uptake during bacteremia in dogs. J Appl Physiol 1987, 63:1487-1492.
17. Zhang H, Smail N, Cabral A, et al.: Hepato-splanchnic blood flow and oxygen extraction capabilities during experimental tamponade: effects of endotoxin. J Surg Res 1999, 81:129-138.
18. Ellis CG, Bateman RM, Sharpe MD, et al.: Effect of a maldistribution of microvascular blood flow on capillary O(2) extraction in sepsis. Am J Physiol 2002, 282:H156-H164.
19. Vincent JL and De Backer D: Oxygen transport - the oxygen delivery controversy. Intensive Care Med 2004, 30:1990-1996.
20. Sun Q, Tu Z, Lobo S, et al.: Optimal adrenergic support in septic shock due to peritonitis. Anesthesiology 2003, 98:888-896.
21. Bernardin G, Pradier C, Tiger F, et al.: Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock. Intensive Care Med 1996, 22:7-25.
22. Levy B, Dusang B, Annane D, et al.: Cardiovascular response to dopamine and early prediction of outcome. A prospective multicenter study. Crit Care Med 2005, 33:2172-2177.
23. Abid O, Akca S, Haji-Michael P, et al.: Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure. Crit Care Med 2000, 28:947-949.
24. Varpula M, Tallgren M, Saukkonen K, et al.: Hemodynamic variables related to outcome in septic shock. Intensive Care Med 2005, 31:1066-1071.
25. LeDoux D, Astiz ME, Carpati CM, et al.: Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000, 28:2729-2732.
26. Bourgoin A, Leone M, Delmas A, et al.: Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 2005, 33:780-786.
27. Cholley BP, Lang RM, Berger DS, et al.: Alterations in systemic arterial mechanical properties during septic shock: role of fluid resuscitation. Am J Physiol 1995, 269: H375-H384.
28. De Backer D, Zhang H, Cherkhaoui S, et al.: Effects of dobutamine on hepato-splanchnic hemodynamics in an experimental model of hyperdynamic endotoxic shock. Shock 2001, 15:208-214.
29. Shoemaker WC, Appel PL, Kram HB, et al.: Sequence of physiologic patterns in surgical septic shock. Crit Care Med 1993, 21:1876-1889.
30. Shoemaker WC, Appel PL, Kram HB, et al.: Temporal hemodynamic and oxygen transport patterns in medical patients: septic shock. Chest 1993, 104:1529-1536.
31. Tuchschmidt J, Fried J, Astiz M, et al.: Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 1992, 102:216-220.
32. Mythen MG and Webb AR.: The role of gut mucosal hypoperfusion in the pathogenesis of post-operative organ dysfunction. Intensive Care Med 1994, 20:203-209.
33. Poeze M, Solberg BC, Greve JW, et al.: Monitoring global volume-related hemodynamic or regional variables after initial resuscitation: What is a better predictor of outcome in critically ill septic patients? Crit Care Med 2005, 33:2494-2500.
34. Gutierrez G, Palizas F, Doglio G, et al.: Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 1992, 339:195-199.
35. Gomersall CD, Joynt GM, Freebairn RC, et al.: Resuscitation of critically ill patients based on the results of gastric tonometry: a prospective, randomized, controlled trial. Crit Care Med 2000, 28:607-614.
36. Schrier RW and Wang W.: Acute renal failure and sepsis. N Engl J Med 2004, 351:159-169.
37. Langenberg C, Bellomo R, May C, et al.: Renal blood flow in sepsis. Crit Care 2005, 9:R363-R374.
38. Baker CH and Wilmoth FR.: Microvascular responses to E. coli endotoxin with altered adrenergic activity. Circ Shock 1984, 12:165-176.
39. Lam CJ, Tyml K, Martin CM, et al.: Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest 1994, 94:2077-2083.
40. Farquhar I, Martin CM, Lam C, et al.: Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. J Surg Res 1996, 61:190-196.
41. McCuskey RS, Urbaschek R, and Urbaschek B.: The microcirculation during endotoxemia. Cardiovasc Res 1996, 32:752-763.
42. De Backer D, Creteur J, Preiser JC, et al.: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002, 166:98-104.
43. Sakr Y, Dubois MJ, De Backer D, et al.: Persistent microvasculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004, 32:1825-1831.
44. Rivers E, Nguyen B, Havstadt S, et al.: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
45. Hollenberg SM, Dumasius A, Easington C, et al.: Characterization of a hyperdynamic murine model of resuscitated sepsis using echocardiography. Am J Respir Crit Care Med 2001, 164:891-895.
46. Gattinoni L, Brazzi L, Pelosi P, et al.: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995, 333:1025-1032.
47. Vincent JL and Weil MH: Fluid challenge revisited. Crit Care Med 2006, 34:1333-1337.
48. Finfer S, Bellomo R, Boyce N, et al.: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247-2256.
49. Sakr Y, Reinhart K, Vincent JL, et al.: Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 2006, 34:589-597.
50. Lopez A, Lorente JA, Steingrub J, et al.: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004, 32:21-30.
51. Sun Q, Dimopoulos G, Nguyen DN, et al.: Low dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med 2003, 168:481-486.
52. Patel BM, Chittock DR, Russell JA, et al.: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002, 96:576-582.
53. Luckner G, Dunser MW, Jochberger S, et al.: Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 2005, 33:2659-2666.
54. Annane D, Bellissant E, Sebille V, et al.: Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 1998, 46:589-597.
55. Annane D, Sebille V, Charpentier C, et al.: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871.
56. Trager K, De Backer D, and Radermacher P.: Metabolic alterations in sepsis and vasoactive drug-related metabolic effects. Curr Opin Crit Care 2003, 9:271-278.
57. De Backer D, Creteur J, Dubois MJ, et al.: The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 2006, 34:403-408.
58. Spronk PE, Ince C, Gardien MJ, et al.: Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002, 360:1395-1396.